TMG (Trimethylglycine): Complete Guide

TMG — trimethylglycine, also known as betaine or betaine anhydrous — is one of the most commonly recommended companion supplements to NMN and NR, yet it is rarely explained with any precision. Many people taking NAD+ precursors add TMG to their stack because they read that it should be included, without a clear understanding of what TMG actually does, why the pairing is recommended, or whether they personally need it. This guide covers all of that: what TMG is, how the methylation cycle works and why it matters, what the clinical evidence shows, why TMG appears in longevity stacks alongside NMN and NR, and what the honest limitations of that rationale are.

What TMG Is and What It Does in the Body

Trimethylglycine is, structurally, the amino acid glycine with three methyl groups attached — hence “tri-methyl-glycine.” It belongs to a category of molecules called betaines, and because it was the first dietary betaine identified (originally isolated from sugar beets), the terms TMG and betaine are used interchangeably in most contexts. It is distinct from betaine hydrochloride (betaine HCl), a different compound used to support stomach acid production — a distinction worth noting because the two are sometimes confused on supplement labels.

In the body, TMG serves two primary functions. First, it is a methyl donor: it can transfer one of its three methyl groups to another molecule, becoming dimethylglycine (DMG) in the process. Second, it functions as an osmolyte — a molecule that cells use to regulate their internal water balance and maintain structural integrity under stress conditions, similar to the role creatine plays. Both functions have biological relevance, but the methyl donor role is the one most directly connected to longevity supplement stacks.

TMG is found naturally in several foods, with beets and beet products being the most concentrated sources. Other meaningful dietary sources include spinach, quinoa, wheat germ, and some seafoods. Dietary intake alone is often insufficient for therapeutic purposes, which is why supplementation is considered when specific methylation support is the goal.

The Methylation Cycle: Why It Matters and Where TMG Fits

Methylation is a fundamental biochemical process in which a methyl group (one carbon atom bonded to three hydrogen atoms) is transferred from one molecule to another. It happens hundreds of millions of times per second in every cell of your body, regulating gene expression, DNA repair, neurotransmitter synthesis, detoxification, and protein function. When the methylation cycle runs efficiently, it produces adequate levels of S-adenosylmethionine (SAMe) — the body’s primary methyl donor, from which most methylation reactions draw their methyl groups.

The cycle works as follows: methionine (an amino acid from dietary protein) is converted into SAMe, which donates a methyl group to perform a biological function and becomes S-adenosylhomocysteine (SAH) in the process. SAH is then hydrolyzed to homocysteine. Homocysteine can be recycled back to methionine through two routes: the folate-B12 pathway (which requires adequate folate and vitamin B12) or the BHMT pathway (betaine-homocysteine methyltransferase), which uses a methyl group from TMG to directly convert homocysteine back to methionine. TMG is the direct methyl donor in this second, faster-acting route.

Homocysteine: The Key Marker the Methylation Cycle Controls

When the methylation cycle runs poorly — due to dietary deficiencies, genetic variants (particularly in the MTHFR gene), or increased methylation demand — homocysteine accumulates in the blood. Elevated homocysteine is one of the most consistently replicated risk markers for cardiovascular disease, with meta-analyses showing that higher homocysteine levels are associated with increased risk of heart disease, stroke, and blood clots. It is also associated with cognitive decline and dementia risk in older adults.

This is where TMG’s most evidence-backed application lies. A well-conducted 2013 systematic review and meta-analysis of randomized controlled trials confirmed that TMG supplementation significantly reduces plasma homocysteine levels in healthy adults — a finding replicated across multiple independent trials at doses ranging from 1,500 mg to 6,000 mg per day. The magnitude of reduction in most trials is 10% to 20%, with larger effects in people with higher baseline homocysteine. This homocysteine-lowering effect is the most robustly supported clinical benefit of TMG supplementation.

It is important to note a significant nuance here: lowering homocysteine as a surrogate marker does not automatically translate into reduced cardiovascular events. Large cardiovascular trials using B vitamins (folate, B6, B12) to lower homocysteine have generally failed to reduce rates of heart attack or stroke, despite successfully lowering homocysteine levels. This disconnect — the marker improves but the clinical outcomes do not follow — is a real limitation in the homocysteine-as-cardiovascular-risk-target hypothesis. TMG’s homocysteine-lowering effect is real and well-evidenced; whether it produces cardiovascular benefit beyond the marker change is less certain. The most appropriate application of TMG for homocysteine remains in people with confirmed elevated levels or known methylation impairment.

TMG’s Other Evidence-Based Applications

Beyond homocysteine, TMG has been studied in several other contexts with varying levels of evidence.

Liver Health

TMG has a meaningful evidence base for liver support, particularly in non-alcoholic fatty liver disease (NAFLD). The liver is the primary site of betaine-mediated homocysteine recycling through the BHMT enzyme, and TMG plays an important role in hepatic lipid metabolism. In animal models, betaine deficiency leads to fatty liver accumulation, and TMG supplementation reverses it. Human data is more limited — the mechanistic evidence is strong, but large randomized controlled trials in humans with NAFLD are not yet published. An FDA-approved pharmaceutical form of TMG called Cystadane is used medically for homocystinuria, a rare genetic condition of severe homocysteine accumulation, establishing the compound’s legitimate therapeutic pedigree.

Athletic Performance

TMG has attracted interest in sports nutrition as a performance enhancer. Several studies have found that TMG supplementation at 2,500 mg per day over several weeks improves power output in trained athletes. A 2013 study published in the Journal of the International Society of Sports Nutrition found that 2,500 mg per day of TMG for two weeks significantly improved muscle endurance and increased total repetitions to failure in bench press and squat exercises. The performance mechanism is thought to operate through both the osmolyte function (improving cell hydration and resilience under exercise stress) and through creatine synthesis support, since TMG is involved in the methylation reactions that produce creatine endogenously. The performance evidence, while not overwhelming, is more consistent than for many sports supplements and is a legitimate non-longevity reason to consider TMG.

Mood and Cognitive Function

TMG’s role in the methylation cycle has led to interest in its potential effects on mood and cognition, since methylation is required for neurotransmitter synthesis (including serotonin, dopamine, and norepinephrine). SAMe — which TMG supports — has a well-established evidence base as an antidepressant adjunct in its own right. However, direct clinical trials testing TMG specifically for depression or cognitive function in humans are limited. One trial found that TMG enhanced the mood benefits of SAMe supplementation when both were taken together, but standalone TMG antidepressant data is sparse. The cognitive and mood rationale for TMG is mechanistically coherent but currently more theoretical than clinically proven.

Why TMG Is Recommended With NMN and NR: The Honest Case

The primary reason TMG appears in longevity stacks alongside NMN and NR is the concern that high-dose NAD+ precursor supplementation may increase methylation demand and deplete methyl groups, potentially raising homocysteine levels as a side effect. Here is how the logic works: when NAD+ is consumed by sirtuins, PARP enzymes, or CD38, nicotinamide is released as a byproduct. Nicotinamide must be methylated before it can be excreted — a process that uses methyl groups drawn from SAMe. If large amounts of NMN or NR are raising NAD+ production and therefore increasing turnover of the NAD+ system, the downstream nicotinamide excretion could in theory draw significantly on the body’s methyl pool, potentially raising homocysteine if methyl availability becomes limiting.

The honest assessment of this rationale is that it is biologically plausible and has some supporting evidence from NR trials — the NR-SAFE Parkinson’s trial, for example, noted a slight transient elevation in homocysteine at the 3,000 mg per day NR dose — but the concern has not been definitively confirmed as clinically significant at typical supplement doses of 250 to 500 mg per day for most healthy people. David Sinclair takes TMG alongside NMN specifically because of this theoretical concern, as do many longevity-focused practitioners who prefer to err on the side of caution.

The practical position most worth adopting: if you are taking NMN or NR at doses of 500 mg per day or more, adding TMG at a reasonable dose (500 to 1,000 mg per day) is a low-cost, low-risk precaution with potential benefit and minimal downside. If you are taking lower doses of NMN or NR, or if you have confirmed normal homocysteine levels, TMG is less clearly necessary. A baseline homocysteine measurement before beginning high-dose NAD+ precursor supplementation, and a recheck after three months, provides the most actionable information about whether TMG is actually needed for you specifically. Our companion article on NMN and TMG together covers the pairing in practical detail.

TMG Dosage: What the Evidence Supports

Human trials have used TMG across a wide dose range: from 500 mg per day in some homocysteine studies to 6,000 mg per day in higher-dose cardiovascular research, and 2,500 mg per day in athletic performance trials. For general methylation support and as a companion to NAD+ precursors in a longevity stack, the most commonly recommended range is 500 mg to 1,500 mg per day. For people with confirmed elevated homocysteine who are supplementing TMG specifically to address it, doses of 1,500 mg to 3,000 mg per day are supported by the clinical literature.

Higher doses (above 3,000 mg per day) are associated with increased risk of gastrointestinal side effects and — notably — may raise LDL cholesterol levels. A controlled trial found that 6,000 mg per day of TMG for six weeks increased LDL cholesterol by approximately 11% and total cholesterol by approximately 8% compared to placebo. This lipid effect is an important safety consideration that is often omitted from TMG marketing content. At doses commonly used in longevity stacks (500 to 1,500 mg per day), this lipid effect has not been consistently observed, but it is a reason to avoid unnecessarily high doses without monitoring.

Taking TMG with meals tends to reduce the likelihood of gastrointestinal discomfort. Splitting the daily dose — half in the morning and half with an evening meal — is a reasonable approach for those taking 1,000 mg or more per day.

Choosing a TMG Supplement: What to Look For

TMG supplements are among the more straightforward to evaluate. The key label specification is “betaine anhydrous” — confirming it is the methylation-relevant form rather than betaine hydrochloride. Products should contain only TMG with minimal fillers. Third-party testing for purity and label accuracy, from a named independent laboratory, is the appropriate quality standard as with all supplements.

TMG is relatively inexpensive, widely available in capsule and powder form, and produced by several reputable manufacturers. Cost per dose is not a meaningful differentiator among quality-verified products — the cheapest well-tested option is generally appropriate.

For context on how TMG fits into a broader supplement approach, see our beginner’s NAD+ stack guide and our article on the advanced longevity stack.

Frequently Asked Questions About TMG

Is TMG the Same as Betaine?

Yes, with one clarification. TMG (trimethylglycine) and betaine refer to the same compound — the terms are used interchangeably. However, “betaine hydrochloride” (betaine HCl) is a different compound used to support stomach acid production, not methylation. When evaluating TMG supplements, look for “betaine anhydrous” on the label to confirm you are getting the methylation-relevant form rather than the digestive acid form.

Does Everyone Taking NMN Need to Take TMG?

Not necessarily. The concern that NMN raises methylation demand enough to deplete methyl groups and elevate homocysteine is biologically plausible but has not been definitively demonstrated at typical supplement doses of 250 to 500 mg per day in healthy adults. If you have confirmed normal homocysteine levels and are taking lower doses of NMN, TMG may not be essential. It becomes a more reasonable precaution at higher NMN or NR doses (500 mg and above), in people with known methylation challenges (such as MTHFR variants), or in those with a family history of cardiovascular disease where homocysteine management is already a priority. Measuring your baseline homocysteine before and after starting NAD+ precursors is the most direct way to determine whether TMG is working for you.

Can TMG Replace Folate and B12 for Homocysteine Management?

No, and this is a meaningful practical point. TMG lowers homocysteine through the BHMT pathway, which is separate from the folate-B12 pathway. Both routes recycle homocysteine back to methionine, but they are independent. In people with elevated homocysteine due to folate or B12 deficiency, TMG will provide some benefit but will not address the root cause. Ensuring adequate folate and B12 status — particularly important for older adults, vegans, and people with MTHFR variants — is the first-line intervention for elevated homocysteine. TMG is best viewed as a complement to, not a substitute for, adequate B vitamin status.

Are There Any Safety Concerns With TMG?

At doses up to 3,000 mg per day, TMG has a generally favorable safety profile. The two most notable concerns are: gastrointestinal discomfort (nausea, diarrhea, stomach upset) at higher doses, which can be mitigated by taking TMG with food and splitting doses; and potential LDL cholesterol elevation at doses of 6,000 mg per day or above, documented in controlled trials. People with cardiovascular concerns or elevated LDL should monitor lipids if using high-dose TMG. At the 500 to 1,500 mg per day range commonly used in longevity stacks, neither concern is prominent, though individual responses vary.

What Foods Are Naturally High in TMG?

Beets and beet products (including beet juice and beet powder) are the richest natural sources — the compound was originally named betaine because of its abundance in sugar beets. Other meaningful sources include spinach, quinoa, wheat germ, wheat bran, and seafood including shrimp. A diet regularly including these foods will provide meaningful dietary TMG, though typically not at the doses used in clinical trials for homocysteine management. For people who eat significant amounts of these foods, the case for supplementing additional TMG is weaker than for those whose diets largely exclude them.